Combination antihypertensive therapy: Does it have a role in rational therapy?

American Journal of Hypertension

Volumn 10, Issue 7 SUPPL. 1, 1997, Pages 131S-137S

  Waeber, Bernard ^a   Brunner, Hans R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antihypertensive drugs; Blood pressure; Compliance; Fixed dose combination therapy; Sequential monotherapy; Tolerability

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; NITRENDIPINE; PLACEBO; PRAZOSIN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG COMBINATION; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION;

EID: 0030844287     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00101-5     Document Type: Article

References (32)

1. Brunner HR, Ménard J, Waeber B, et al: Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and fixed-dose combinations. J Hypertens 1990;8:3-11.
2. Sever P: The heterogeneity of hypertension: why doesn't every patient respond to every antihypertensive drug? J Hum Hypertens 1995;9(suppl 2):33-36.
3. 1993 Guidelines for the Management of Mild Hypertension. Memorandum from a World Health Organization/International Society of Hypertension Meeting. Hypertension 1993;22:392-403.
4. Jones JK, Gorkin L, Lian JF, et al: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995;311:293-295.
5. Materson BJ, Reda DJ, Cushman WC, et al for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328:914-921.
6. Fagan TC: Remembering the lessons of basic pharmacology. Arch Intern Med 1994;154:1430-1431.
7. Waeber G, Beck G, Waeber B, et al: Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures. J Hypertension 1988;6:239-245.
8. Bidiville J, Nussberger J, Waeber G, et al: Individual responses to converting enzyme inhibitors and calcium antagonists. Hypertension 1988;11:166-173.
9. Attwood S, Bird R, Burch K, et al: Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertens 1994;12:1053-1060.
10. Chalmers J: The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens 1993;15:1299-1313.
11. Brunner HR, Gavras H, Waeber B: Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade. Clin Exp Hypertension 1980;2:639-657.
12. Weinberger MH: Influence of an angiotensin-converting enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983;5(suppl III):132-138.
13. Chrysant SG: for the Lisinopril-Hydrochlorothiazide Group. Antihypertensive effectiveness of a low-dose lisinopril-hydrochlorothiazide combination. Arch Intern Med 1994;154:737-743.
14. Malacco E, Casini A, Conti C: Antihypertensive treatment in adults and the elderly with a combination of captopril plus hydrochlorothiazide. Current Ther Res 1981;50:570-578.
15. Frishman WH, Bryzinski BS, Coulson LR, et al: A multifactorial trial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1462-1472.
16. Fenichel RC, Lipicky RJ: Combination products as first-line pharmacotherapy. Arch Intern Med 1994;154: 1429-1430.
17. Prisant ML, Weir MR, Papademetriou V, et al: Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130:359-366.
18. Dahlöf B, Hosie J, for the Swedish/United Kingdom Study Group: Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. J Cardiovasc Pharmacol 1990;16:910-916.
19. Dahlöf B, Jönsson L, Borgholst O, et al: Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone. Blood Pressure 1993;2(suppl 1):37-45.
20. Salvetti A, Innocenti PF, Lardella M, et al: Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens 1987; 5(suppl 4):139-142.
21. Gennari C, Nami R, Pavese G, et al: Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Drugs Ther 1989;3:319-325.
22. Fitscha P, Meisner W, Hitzenberger G: Antihypertensive effects of isradipine and captopril as monotherapy or in combination. Am J Hypertens 1991;4:151s-153s.
23. Hansson L: Beta-blockers with ACE inhibitors - a logical combination? J Hum Hypertens 1989;3:97-100.
24. Lüscher TF, Waeber B: Calcium antagonists as first line therapy in hypertension: results of the Swiss Isradipine Study. J Cardiovasc Pharmacol 1991;18(suppl 3):1-3.
25. Pool PE, Applegate WB, Woehler T, et al: A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension. Pharmacotherapy 1993;13:487-493.
26. Salvetti A, Magagna A, Innocenti P, et al: Chlortalidone does not increase the hypotensive effect of nifedipine in essential hypertensives: a crossover multicentre study. J Hypertens 1989;7:S250-S251.
27. Letellier P, Overlack A, Agnes E, Desche P, and the Multicentre Study Group on Treatment Association with Perindopril: Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. J Hum Hypertens 1994;8:145-149.
28. Dollery CT: Pharmacological basis for combination therapy of hypertension. Ann Rev Pharmacol Toxicol 1977;17:311-323.
29. Oster JR, Epstein M: Fixed-dose combination medications for the treatment of hypertension: a critical review. J Clin Hypertens 1987;3:278-293.
30. Messerli FH: Combination therapy in hypertension. J Hum Hypertens 1992;6(suppl 2):S19-S21.
31. Sica DA: Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs 1994;48:16-24.
32. Waeber B, Brunner HR: Main objectives and new aspects of combination treatment of hypertension. J Hypertens 1995;13(suppl 2):15-19.